Can Genetic Screening Reduce the Risk of Passing Inherited Disorders to Future Generations?

Every year in India, thousands of children are born with serious genetic conditions that their parents never saw coming. Not because the parents were careless, and not because the conditions appeared without warning, but because the warning existed entirely in the parents' DNA, was never detected, and was therefore never acted upon. Genetic screening changes this. It does not alter anyone's DNA. What it does is make the invisible visible, early enough and with enough clarity, that families can make genuinely informed decisions. Can genetic screening actually reduce the risk of passing inherited disorders to future generations? The answer, grounded in clinical evidence and Indian-specific data, is yes.

Understanding How Inherited Disorders Are Passed Down

The majority of conditions detected through carrier screening are autosomal recessive. A child must inherit two faulty copies of the same gene, one from each parent, to develop the condition. If both parents are carriers, there is a 25% chance with each pregnancy that the child inherits two defective copies and develops the disorder, a 50% chance the child is a carrier but healthy, and a 25% chance the child is completely unaffected. Since carriers typically show no symptoms, these conditions can be passed down silently through generations. This is why family history is not a reliable safety net: a couple with no affected relatives can both be carriers, because carriers in previous generations simply happened not to marry other carriers. Genetic screening detects carrier status before that first affected child is the signal.

What the Indian Data Actually Shows

India is not a low-risk country for inherited genetic disorders. Globally, monogenic conditions occur in approximately 1 in 250 births. In India, the burden is elevated by endogamous marriages within specific communities, extended family networks, and historically low awareness of carrier status. A landmark study at Sir Ganga Ram Hospital in New Delhi screened 200 unrelated North Indian individuals for pathogenic variants in 88 genes using next-generation sequencing. Of the 200 participants, 52, representing 26 per cent, were found to be carriers of one or more disorders. One in four North Indian individuals tested was a carrier of at least one serious inherited condition. Twelve were carriers for congenital deafness (one in 17 for the four deafness genes tested), and nine were carriers for cystic fibrosis (one in 22).

The Conditions Indian Couples Should Screen For

Thalassemia remains the most urgent, with an estimated 40 million Indian carriers. Sickle cell disease is critically relevant for tribal and community populations across Maharashtra, Gujarat, Madhya Pradesh, Chhattisgarh, Odisha, and Jharkhand, where carrier rates reach 20 to 30 percent in some communities. Spinal muscular atrophy causes degeneration of motor neurons and is typically fatal before age two in its most severe form, with carrier frequency around 1 in 40 to 1 in 50. Congenital deafness emerged as one of the highest carrier frequencies in the North Indian study (one in 17). Cystic fibrosis, Duchenne muscular dystrophy, Pompe disease, and dozens of other conditions are included in modern expanded carrier screening panels that use next-generation sequencing to assess hundreds of genes simultaneously.

How Genetic Screening Actually Reduces Transmission Risk

When carrier screening identifies that both partners carry the same recessive variant, identifying that risk transforms the family's options from zero to several. Option 1: Informed natural conception with prenatal testing (NIPT, CVS, or amniocentesis), making informed decisions if the foetus is affected. Option 2: IVF with preimplantation genetic testing (PGT-M), the most direct route, where embryos are tested for the specific condition and only unaffected embryos are transferred, producing a pregnancy with no risk of that condition. A study of 572 IVF cycles using PGT-M found clinical pregnancy and live birth rates per transfer of 51.3% and 44.8%. Option 3: Donor gametes from a tested non-carrier. Option 4: Informed family planning and support with full understanding of the risk. Each option is meaningful and only available because the couple knew in time.

The Public Health Scale of This Issue

A modelling study showed that at an uptake rate of 50%, expanded reproductive carrier screening for a 300-condition panel would avert 2,290 more affected births in a single birth cohort. Applied to India, where birth cohorts number over 25 million per year, the public health mathematics of widespread carrier screening are strikingly positive. Research in Singapore confirmed that population-specific screening panels are essential for Asian communities: standard global panels built primarily on Western population data miss variants common in Indian populations, so the clinical relevance of carrier screening for Indian couples depends on panels developed with Indian genomic data in mind.

The Difference Between Reducing Risk and Eliminating It

Genetic screening reduces transmission risk; it does not eliminate it. New mutations that arise for the first time in a generation cannot be predicted by parental carrier testing, some conditions have complex inheritance patterns, and any individual test has technical limits. What carrier screening does with high reliability is identify the most common and clinically significant autosomal recessive conditions in both partners and equip couples to make decisions that reflect their values. The goal of screening is not a guarantee. It is knowledge, delivered early enough to be useful.

Why Timing Is Everything

The window in which carrier screening delivers its full value is before conception. Screening before conception gives access to all options, including IVF with PGT-M. Screening during pregnancy still provides valuable information but narrows the timeline and eliminates some pre-conception options. Screening after a child is born affected provides a diagnosis and pathway to care, but arrives too late for prevention. The earlier the conversation, the more options remain open. MatchGenesNow makes carrier screening as straightforward as current technology allows: a simple saliva swab from each partner collected at home, both kits sent together, processed at certified partner laboratories using next-generation sequencing, with results shared in a joint genetic counselling session.

Frequently Asked Questions

Can genetic screening guarantee my child will not have an inherited disorder? No. It significantly reduces the risk of passing on specific identified conditions, but cannot provide a complete guarantee. Not all genetic conditions are caused by detectable parental carrier variants, and new mutations can arise. What screening does is identify the most common and clinically significant risks, providing actionable knowledge while there is maximum time and options available.

What is the difference between carrier screening and prenatal testing? Carrier screening tests the parents before conception to identify whether either or both carry recessive variants. Prenatal testing examines the foetus during pregnancy. Both are valuable, but carrier screening before conception provides the widest range of reproductive options, including IVF with preimplantation genetic testing.

What is preimplantation genetic testing and how does it prevent inherited disorders? PGT-M involves testing embryos created through IVF for a specific genetic condition before transfer. Only embryos unaffected by the tested condition are selected for transfer, effectively preventing transmission of that specific disorder without requiring decisions during pregnancy.

We have no family history of genetic disease. Do we still need carrier screening? Yes. The majority of children born with serious recessive conditions have parents with no known family history, because carrier parents are completely healthy. Family history is not a reliable substitute for actual testing.

Which conditions does MatchGenesNow screen for? The panel covers the conditions most clinically relevant to Indian couples, including thalassemia, sickle cell disease, spinal muscular atrophy, congenital deafness, cystic fibrosis, Duchenne muscular dystrophy, and dozens of other autosomal recessive conditions, built using next-generation sequencing and reflecting Indian carrier frequencies.

If we are both carriers of the same condition, what are our options? Four main pathways: natural conception with prenatal testing, IVF with PGT-M to transfer only unaffected embryos, donor gametes from a tested non-carrier, or natural conception with a fully informed care plan. A certified genetic counsellor will guide the couple through every option.

How accurate is carrier screening? Modern carrier screening using next-generation sequencing achieves high sensitivity for the variants included in the panel, typically detecting more than 95% of carrier cases for well-characterised conditions. Residual risk varies by condition and is disclosed transparently in every report.